This investment was essential to satisfy the ever-increasing demand on Béres products both in Hungary and abroad and necessary to increase production capacities. The company purchased two pieces of new, high-performance production equipment, and following the modifications specified by pharmaceutical regulations for particular production areas, it significantly increased the company’s tablet production and packaging capacities.
The development of the Szolnok plant has a message: the increase of product sales, as well as the development and market launch of new health protection products are seen by Béres as central strategic responsibilities. In the last 25 years, Béres has established a stable market leading position on the Hungarian health productection market with a market share of 35% in 2014. Béres products are market leaders on the market of immune boosters, complex multivitamins-minerals-trace elements preprarations, food supplements, vitamins and minerals product families, the whole of the vitamin C market, as well as on the market of complex calcium supply medicines.
Béres is a true Hungrian success story; 25 years after its establishment, it is an independent company group with a positive image of the future.
„Our products are created in our modern development laboratory in Budapest and our production is of world class standard taking place in our own pharmaceuticals production plant in Szolnok. As the largest pharmaceuticals company in Hungarian ownership in Hungary, we return our profits to value-creating investments that stand the test of time, such as the new Szolnok production unit inagurated just now” – pointed out Dr. József Béres president of Béres Pharmaceuticals.